4
Changes in Ownership
Contineum Therapeutics, Inc. Filed Acc 0001437749-25-038936
Chief Scientific Officer sold 4,170 shares at $12.23 ($51,009)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lorrain Daniel S. · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-23 | Sale : show line 1 in the form 10b5-1 | −4,170 | $12.23 | $51,009 | 164,392 | D |
| Open-market sales · 4,170 sh · avg $12.23 · $51,009 | ||||||
Loading xslF345X05/rdgdoc.xml…